CLINICAL_TRIALS
ClinicalTrials.gov record update
The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic Tumors
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT06911710
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:26:38.696971+00:00
- Published At
- 2025-04-04T00:00:00+00:00
- Record Updated At
- 2025-04-04
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Lymphoma, B-cell, Aggressive Non-Hodgkin (B-NHL)", "AML (Acute Myelogenous Leukemia)", "Myeloma Multiple", "B-ALL", "T-ALL/Lymphoma", "T-lymphocyte Lymphoma"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-04-04"- protocolSection.identificationModule.nctId
"NCT06911710"- protocolSection.identificationModule.officialTitle
"The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic Tumors"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["PHASE1", "PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.